Dhahiri S Mashausi

Title: Dhahiri S Mashausi: Innovator in Monoclonal Antibody Research

Introduction

Dhahiri S Mashausi is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His innovative work focuses on therapeutic applications that can potentially impact cancer treatment.

Latest Patents

Dhahiri S Mashausi holds a patent for an AGR2 blocking antibody and its use. This patent discloses a humanized monoclonal antibody designed to block AGR2, which is crucial in tumor growth and metastasis. The patent also includes a pharmaceutical composition containing the antibody and a method for its preparation.

Career Highlights

Throughout his career, Dhahiri has worked with notable organizations, including Sanofi (China) Investment Co., Ltd. Shanghai Branch and Shanghai Jiaotong University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Some of his notable coworkers include Dawei Li and Zhenghua Wu. Their collaboration has likely enhanced the research and development of innovative solutions in the field of monoclonal antibodies.

Conclusion

Dhahiri S Mashausi's work in developing AGR2 blocking antibodies showcases his commitment to advancing cancer treatment through innovative research. His contributions are significant in the ongoing fight against cancer, and his patent reflects the potential for future therapeutic applications.